These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7290983)

  • 1. Clinical presentation of thalassemia major due to homozygous beta (0)-thalassemia.
    Galanello R; Cossu P; Pirastu M; Cao A
    Nouv Rev Fr Hematol (1978); 1981; 23(2):101-6. PubMed ID: 7290983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Globin chain synthesis analysis in obligate beta 0-thalassemia heterozygotes with isolated increase of hemoglobin A2 levels.
    Galanello R; Melis MA; Furbetta M; Angius A; Scalas MT; Paglietti E; Cao A
    Nouv Rev Fr Hematol (1978); 1981; 23(4):193-5. PubMed ID: 7312613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalassemia in the outpatient department of the Yangon Children's Hospital in Myanmar: basic hematological values of thalassemia traits.
    Khin Ei Han ; Aung Myo Han ; Kyaw Win ; Thein Thein Myint
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):264-8. PubMed ID: 1439979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the epidemiology of thalassemia in North America: a new minority disease.
    Vichinsky EP; MacKlin EA; Waye JS; Lorey F; Olivieri NF
    Pediatrics; 2005 Dec; 116(6):e818-25. PubMed ID: 16291734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-inheritance of alpha and beta-thalassemia in a Jordanian family.
    Al Qaddoumi AA
    Clin Lab Sci; 2006; 19(3):165-8. PubMed ID: 16910233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
    Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades.
    Pearson HA; Cohen AR; Giardina PJ; Kazazian HH
    Pediatrics; 1996 Mar; 97(3):352-6. PubMed ID: 8604269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha and beta thalassemia.
    Muncie HL; Campbell J
    Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum transferrin receptor levels in common types of thalassemia heterozygotes in Southeast Asia: a correlation with genotypes and red cell indices.
    Uaprasert N; Rojnuckarin P; Bhokaisawan N; Settapiboon R; Wacharaprechanont T; Amornsiriwat S; Sutcharitchan P
    Clin Chim Acta; 2009 May; 403(1-2):110-3. PubMed ID: 19361457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to hydroxyurea therapy in beta-thalassemia.
    Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
    Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of thalassemia intermedia in Iran.
    Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
    Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma chitotriosidase activity in patients with beta-thalassemia.
    Altarescu G; Rudensky B; Abrahamov A; Goldfarb A; Rund D; Zimran A; Elstein D
    Am J Hematol; 2002 Sep; 71(1):7-10. PubMed ID: 12221666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thalassaemia intermedia. Clinical and laboratory study. Therapeutic suggestions (author's transl)].
    Triadou P; Girot R; Lapoumeroulie C; Pomarede R; Constant S
    Nouv Presse Med; 1982 Jan; 11(4):253-6. PubMed ID: 6173844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent thalassemias: genotypes and phenotypes.
    Bianco I; Cappabianca MP; Foglietta E; Lerone M; Deidda G; Morlupi L; Grisanti P; Ponzini D; Rinaldi S; Graziani B
    Haematologica; 1997; 82(3):269-80. PubMed ID: 9234571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic significance of hemoglobin F and A2 levels in homo- and heterozygous beta-thalassemia during infancy.
    Schröter W; Nafz C
    Helv Paediatr Acta; 1981; 36(6):519-25. PubMed ID: 6174481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin H disease in the eastern region of Saudi Arabia.
    Qadri MI; Islam SA
    Saudi Med J; 2000 Jul; 21(7):666-71. PubMed ID: 11500731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India.
    Garewal G; Das R; Ahluwalia J; Marwaha RK; Varma S
    Am J Hematol; 2005 Aug; 79(4):252-6. PubMed ID: 16044458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alternatively spliced beta E-globin mRNA on clinical severity of beta-thalassemia/hemoglobin E disease.
    Winichagoon P; Fucharoen S; Wilairat P; Chihara K; Fukumaki Y
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():241-5. PubMed ID: 8629114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell phenotypes in alpha-thalassemias in the Spanish population.
    Villegas A; Porres A; Sánchez J; González FA; Pérez-Clausell C; Martínez M; Murga MJ; Cachá J; Lozano M; Fernández-Fuertes I; Del Arco A; Arrizabalaga B; Pérez de Mendiguren B; San Juan I; Saavedra R; Ricart P; Sainz C; Guerra JL; Muñoz JA; Lago C; Ansó VM
    Haematologica; 1998 Feb; 83(2):99-103. PubMed ID: 9580456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.